MAI CDMO Network Collaborates with IMAPAC for Biologics CDMO Europe 2025

Connecting Leaders in Biologics Manufacturing

MAI CDMO is proud to announce its collaboration with IMAPAC for Biologics CDMO Europe 2025, an exclusive summit taking place on 19–20 November in Munich, Germany.

This event brings together external manufacturing leaders and biopharma innovators from across Europe in a highly focused, closed-door environment. Unlike traditional conferences or crowded expo floors, CDMO Europe emphasizes real conversations, strategic networking, and high-level discussions designed to drive meaningful collaboration.

What makes this summit unique?

• Exclusivity by design: Every delegate, speaker, and partner is carefully selected for strategic alignment.
• Depth over buzzwords: Expect off-the-record discussions, practical case studies, and forward-thinking insights.
• Precision networking: Personalised meetings and executive roundtables ensure that every interaction is intentional and valuable.

Attendees will engage in dialogue on critical topics, including:

• Building agile, tech-enabled, and future-proof manufacturing models
• Navigating cross-border partnerships and evolving EU regulatory frameworks
• Resilience, scalability, and sustainability in biologics outsourcing
• Managing talent and capacity in a competitive, post-pandemic ecosystem

The summit will feature leaders from across the European biomanufacturing ecosystem, including CTOs, MSAT Directors, Heads of External Manufacturing, and global biopharma decision-makers from top organizations.

For MAI CDMO, this collaboration represents a valuable opportunity to support knowledge exchange, strengthen industry partnerships, and stay at the forefront of biologics manufacturing innovation.

For more information and to register for the event, visit: https://www.imapac.com/events/cdmo-europe-2025?utm_campaign=15405655-CDMOEU2025&utm_source=media_partner&utm_medium=maicdmo&utm_term=registration#register